5568 related articles for article (PubMed ID: 29628281)
1. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.
;
J Hepatol; 2018 Jul; 69(1):182-236. PubMed ID: 29628281
[No Abstract] [Full Text] [Related]
2. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.
Kudo M; Izumi N; Kokudo N; Matsui O; Sakamoto M; Nakashima O; Kojiro M; Makuuchi M;
Dig Dis; 2011; 29(3):339-64. PubMed ID: 21829027
[TBL] [Abstract][Full Text] [Related]
3. World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective.
Ferenci P; Fried M; Labrecque D; Bruix J; Sherman M; Omata M; Heathcote J; Piratsivuth T; Kew M; Otegbayo JA; Zheng SS; Sarin S; Hamid S; Modawi SB; Fleig W; Fedail S; Thomson A; Khan A; Malfertheiner P; Lau G; Carillo FJ; Krabshuis J; Le Mair A;
J Gastrointestin Liver Dis; 2010 Sep; 19(3):311-7. PubMed ID: 20922197
[No Abstract] [Full Text] [Related]
4. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease.
;
J Hepatol; 2018 Jul; 69(1):154-181. PubMed ID: 29628280
[No Abstract] [Full Text] [Related]
5. Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.
; ; ; ; ; ; ; ; ;
J Formos Med Assoc; 2018 May; 117(5):381-403. PubMed ID: 29074347
[TBL] [Abstract][Full Text] [Related]
6. Current Guidelines for the Diagnosis and Management of Hepatocellular Carcinoma: A Comparative Review.
Arslanoglu A; Seyal AR; Sodagari F; Sahin A; Miller FH; Salem R; Yaghmai V
AJR Am J Roentgenol; 2016 Nov; 207(5):W88-W98. PubMed ID: 27490855
[TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolisation is not superior to embolisation alone: the recent European Association for the Study of the Liver (EASL) - European Organisation for Research and Treatment of Cancer (EORTC) guidelines.
Tsochatzis E; Meyer T; O'Beirne J; Burroughs AK
Eur J Cancer; 2013 Apr; 49(6):1509-10. PubMed ID: 23231982
[No Abstract] [Full Text] [Related]
8. [Hepatocellular carcinoma - current aspects of screening, surveillance and therapeutic strategies (revised EASL-EORTC recommendations)].
Roeb E
Zentralbl Chir; 2014 Apr; 139(2):175-83. PubMed ID: 24132679
[TBL] [Abstract][Full Text] [Related]
9. Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference.
Dufour JF; Johnson P
J Hepatol; 2010 Feb; 52(2):296-304. PubMed ID: 20006399
[No Abstract] [Full Text] [Related]
10. Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment.
Kim MN; Kim BK; Han KH; Kim SU
Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):335-48. PubMed ID: 25370168
[TBL] [Abstract][Full Text] [Related]
11. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.
;
Eur J Cancer; 2012 Mar; 48(5):599-641. PubMed ID: 22424278
[No Abstract] [Full Text] [Related]
12. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.
Kudo M; Okanoue T;
Oncology; 2007; 72 Suppl 1():2-15. PubMed ID: 18087177
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Jelic S;
Ann Oncol; 2009 May; 20 Suppl 4():41-5. PubMed ID: 19454459
[No Abstract] [Full Text] [Related]
14. AHPBA/SSO/SSAT sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma.
Dixon E; Abdalla E; Schwarz RE; Vauthey JN
HPB (Oxford); 2010 Jun; 12(5):287-8. PubMed ID: 20590900
[No Abstract] [Full Text] [Related]
15. [Liver cancer: progress in diagnosis and treatments. Topics: IV. Progress in guideline on liver cancer; 2. Treatment algorithm and clinical practice guidelines for hepatocellular carcinoma].
Nakayama H; Takayama T
Nihon Naika Gakkai Zasshi; 2014 Jan; 103(1):31-6. PubMed ID: 24605488
[No Abstract] [Full Text] [Related]
16. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.
Omata M; Cheng AL; Kokudo N; Kudo M; Lee JM; Jia J; Tateishi R; Han KH; Chawla YK; Shiina S; Jafri W; Payawal DA; Ohki T; Ogasawara S; Chen PJ; Lesmana CRA; Lesmana LA; Gani RA; Obi S; Dokmeci AK; Sarin SK
Hepatol Int; 2017 Jul; 11(4):317-370. PubMed ID: 28620797
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of guidelines for management of intermediate hepatocellular carcinoma using the Appraisal of Guidelines Research and Evaluation II instrument.
Holvoet T; Raevens S; Vandewynckel YP; Van Biesen W; Geboes K; Van Vlierberghe H
Dig Liver Dis; 2015 Oct; 47(10):877-83. PubMed ID: 26250948
[TBL] [Abstract][Full Text] [Related]
18. Dissemination of evidence-based clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists, liver surgeons and primary care physicians.
Kokudo N; Sasaki Y; Nakayama T; Makuuchi M
Gut; 2007 Jul; 56(7):1020-1. PubMed ID: 17566034
[No Abstract] [Full Text] [Related]
19. Consensus and controversy in the management of hepatocellular carcinoma.
Kim RD; Reed AI; Fujita S; Foley DP; Mekeel KL; Hemming AW
J Am Coll Surg; 2007 Jul; 205(1):108-23. PubMed ID: 17617340
[No Abstract] [Full Text] [Related]
20. [Comparison of the clinical practice guidelines for hepatocellular carcinoma in Japan and Western countries].
Ikai I
Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):343-8. PubMed ID: 19068716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
